Gut‐liver axis: Potential mechanisms of action of food‐derived extracellular vesicles

Author:

Zhang Sitong12,Wang Qiyue34,Tan Daniel En Liang12,Sikka Vritika12,Ng Cheng Han5,Xian Yan12,Li Dan6,Muthiah Mark57,Chew Nicholas W. S.8,Storm Gert1,Tong Lingjun34ORCID,Wang Jiong‐Wei12910ORCID

Affiliation:

1. Department of Surgery, Yong Loo Lin School of Medicine National University of Singapore Singapore Singapore

2. Nanomedicine Translational Research Programme, Centre for NanoMedicine, Yong Loo Lin School of Medicine National University of Singapore Singapore Singapore

3. Jinan Central Hospital Shandong First Medical University & Shandong Academy of Medical Sciences Jinan China

4. Medical Science and Technology Innovation Center Shandong First Medical University & Shandong Academy of Medical Sciences Jinan China

5. Division of Gastroenterology and Hepatology, Department of Medicine National University Hospital Singapore Singapore

6. Department of Food Science and Technology, Faculty of Science National University of Singapore Singapore Singapore

7. National University Centre for Organ Transplantation National University Health System Singapore Singapore

8. Department of Cardiology National University Heart Centre National University Health System Singapore Singapore

9. Cardiovascular Research Institute (CVRI) National University Heart Centre Singapore (NUHCS) Singapore Singapore

10. Department of Physiology, Yong Loo Lin School of Medicine National University of Singapore Singapore Singapore

Abstract

AbstractFood‐derived extracellular vesicles (FEVs) are nanoscale membrane vesicles obtained from dietary materials such as breast milk, plants and probiotics. Distinct from other EVs, FEVs can survive the harsh degrading conditions in the gastrointestinal tract and reach the intestines. This unique feature allows FEVs to be promising prebiotics in health and oral nanomedicine for gut disorders, such as inflammatory bowel disease. Interestingly, therapeutic effects of FEVs have recently also been observed in non‐gastrointestinal diseases. However, the mechanisms remain unclear or even mysterious. It is speculated that orally administered FEVs could enter the bloodstream, reach remote organs, and thus exert therapeutic effects therein. However, emerging evidence suggests that the amount of FEVs reaching organs beyond the gastrointestinal tract is marginal and may be insufficient to account for the significant therapeutic effects achieved regarding diseases involving remote organs such as the liver. Thus, we herein propose that FEVs primarily act locally in the intestine by modulating intestinal microenvironments such as barrier integrity and microbiota, thereby eliciting therapeutic impact remotely on the liver in non‐gastrointestinal diseases via the gut‐liver axis. Likewise, drugs delivered to the gastrointestinal system through FEVs may act via the gut‐liver axis. As the liver is the main metabolic hub, the intestinal microenvironment may be implicated in other metabolic diseases. In fact, many patients with non‐alcoholic fatty liver disease, obesity, diabetes and cardiovascular disease suffer from a leaky gut and dysbiosis. In this review, we provide an overview of the recent progress in FEVs and discuss their biomedical applications as therapeutic agents and drug delivery systems, highlighting the pivotal role of the gut‐liver axis in the mechanisms of action of FEVs for the treatment of gut disorders and metabolic diseases.

Funder

Natural Science Foundation of Shandong Province

Shandong First Medical University

National University of Singapore

Publisher

Wiley

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3